We are thrilled to announce that TAmiRNA, Evercyte, and Phoenestra have united to form EVscale™, a powerful collaboration dedicated to providing comprehensive solutions for extracellular vesicle (EV) research, diagnostic, and therapeutic development. We will be exhibiting at the prestigious ISEV (International Society for Extracellular Vesicles) Conference in Vienna from April 24-27, 2025, and we invite you to visit us at Booth B13.
The EV Scale platform is designed to streamline every step of your EV workflow, catering to both therapeutic development and sophisticated omics-based biomarker discovery. Leveraging the unique expertise of each partner, we offer an integrated approach that encompasses:
- Optimized EV Production for Therapeutics: Utilizing a range of high-quality mesenchymal stromal cell (MSC) lines from Evercyte, chosen for their superior EV production capabilities, particularly relevant for therapeutic applications.
- Scalable Bioreactor Technology for Clinical Translation: Employing advanced bioreactor systems from Phoenestra for efficient and scalable EV production, ensuring the necessary quantities for preclinical studies and future clinical trials.
- Advanced EV cargo characterization: Providing in-depth characterization services, including comprehensive omics analysis (transcriptomics and proteomics) and precise particle analysis using NTA and NanoFCM. TAmiRNA’s specialized expertise is particularly valuable in analyzing microRNAs, mRNAs, and lncRNAs to identify and validate novel EV biomarkers.
Attending ISEV Vienna from April 24-27, 2025? This is a fantastic opportunity to:
- Meet the EVscale™ Team: Connect with experts from TAmiRNA, Evercyte, and Phoenestra at ISEV to discuss your specific EV research goals, whether focused on developing novel therapies or leveraging omics for EV characterization and biomarker discovery.
- Discover Our Integrated Platform: Learn how our end-to-end solutions can simplify your EV production and characterization processes, supporting both therapeutic and diagnostic applications with advanced analytical techniques like transcriptomics and proteomics.
- Explore the Synergy for Diverse Applications: Understand how the collaboration between our companies can accelerate your EV research and development across various fields, particularly in areas requiring detailed omics profiling for biomarker discovery.
We are excited to be part of the ISEV community from April 23-27, 2025, and look forward to showcasing the power of EV Scale. Visit us at Booth B13 to explore how our integrated platform can elevate your EV research, from robust therapeutic production to cutting-edge omics-driven biomarker discovery.
Stay tuned for more updates as we approach the conference!
We look forward to seeing you in Vienna!
About EV Scale:
EVscale™ is a collaboration between TAmiRNA, Evercyte, and Phoenestra, dedicated to providing comprehensive and integrated solutions for extracellular vesicle (EV) research and production. By combining expertise in cell line development, scalable production, and advanced characterization including omics (transcriptomics and proteomics) and NanoFCM, EV Scale empowers researchers and companies to accelerate their EV-related endeavors in both therapeutic development and biomarker discovery, with a special focus on miRNA, mRNA/lncRNA analysis.
